| Literature DB >> 32131464 |
Qing Fang1, Fleurdeliz Maglangit1,2, Morgane Mugat3, Caroline Urwald3, Kwaku Kyeremeh4, Hai Deng1.
Abstract
Four compounds (1-4) were isolated from the extracts of Streptomyces sp. CT37 using bioassay in conjunction with mass spectrometric molecular networking (MN) driven isolation. Their complete structures were established by high-resolution electrospray ionization mass spectrometry (HR-ESIMS), and 1D and 2D nuclear magnetic resonance (NMR) data. Legonimide 1 was identified as a new alkaloid containing a rare linear imide motif in its structure, while compounds 2-4 were already known and their structures were elucidated as 1H-indole-3-carbaldehyde, actinopolymorphol B, (2R,3R)-1-phenylbutane-2,3-diol, respectively. The biosynthetic pathways of 1-4 were proposed based on the reported biogenesis of indole alkaloids in literature. Bioactivity tests for 1 and 2 revealed moderate growth inhibition activity against Candida albicans ATCC 10231 with MIC95 values of 21.54 µg/mL and 11.47 µg/mL, respectively.Entities:
Keywords: Streptomyces sp. CT37; antifungal; imide; indole alkaloids; legonimide; natural products
Mesh:
Substances:
Year: 2020 PMID: 32131464 PMCID: PMC7179168 DOI: 10.3390/molecules25051108
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Compounds 1–4 isolated from Streptomyces sp. CT37 ISP2 extract; compound 1 with correlation spectroscopy (COSY) (―) and key heteronuclear multiple bond correlation (HMBC) (→) correlations.
1H and 13C NMR assignments of legonimide 1 (600MHz, 298K, DMSO-d).
| Position | 1H (mult., | 13C |
|---|---|---|
| 1-NH | 10.96 (1H, s) | - |
| 2 | 7.18 (1H, s) | 123.6 |
| 3 | - | 109.2 |
| 4a | - | 127.3 |
| 4 | 7.54 (1H, d, | 118.7 |
| 5 | 7.02 (1H, t, | 118.5 |
| 6 | 7.06 (1H, t, | 120.8 |
| 7 | 7.34 (1H, d, | 111.3 |
| 7a | - | 136.5 |
| 8 | 3.46(2H, s) | 32.4 |
| 9 | - | 173.1 |
| 10-NH | 7.37 (1H, s) | - |
| 11 | - | 172.3 |
| 12 | 3.35(2H, s) | 42.0 |
| 13 | - | 136.6 |
| 14,14′ | 7.28 (2H, d, | 128.1 |
| 15,15′ | 7.21 (2H, m) | 126.4 |
| 16 | 7.31 (1H, m) | 126.3 |
Figure 2Proposed biosynthesis pathway of 1–4.
Minimum inhibitory concentration of compounds 1–4 against C. albicans 10231.
| Legonimide | 21.54 |
| Compound | 11.47 |
| Compound | >50 |
| Compound | >50 |
| Ampicillin | 3.193 |
| Tetracycline | 0.3615 |